Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Monoclonal antibodies and chimeric antigen receptor (CAR) T cells in the treatment of colorectal cancer

Fig. 2

Overview of CAR-T cell therapy. The blood of the patient is collected and T cells are isolated. T cells are then genetically altered to express specific receptors for binding to certain targets on the cancer cells. The generated CAR-T cells are cultivated and expanded in vitro. Finally, CAR-T cells are infused into the patient’s bloodstream to kill the tumor cells

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us